The quantitative impact of prostate-specific membrane antigen (PSMA) PET/CT staging in newly diagnosed metastatic prostate cancer and treatment-decision implications

BJR|open · Published 2023-12-12 · DOI 10.1093/bjro/tzae040

Authors being retrieved — see the publisher record. https://doi.org/10.1093/bjro/tzae040

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2023

Related articles